General information about company |
|||
|---|---|---|---|
| Scrip Code | 533179 | ||
| NSE Symbol | PERSISTENT | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE262H01016 | ||
| Name of company | Persistent Systems Limited | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2025 | ||
| Date of end of financial year | 31-Mar-2026 | ||
| Date of board meeting when results were approved | 23-Jul-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 24-Jun-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | First quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Audited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |||
| Segment Reporting | Multi segment | ||
| Description of single segment | |||
| Start date and time of board meeting | 23-Jul-2025 08:00:00 | ||
| End date and time of board meeting | 23-Jul-2025 16:16:00 | ||
| Whether cash flow statement is applicable on company | |||
| Type of cash flow statement | |||
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Audited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 33335870000 | ||
| Other income | 546620000 | ||
| Total income | 33882490000 | ||
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | |
| (b) | Purchases of stock-in-trade | 0 | |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | |
| (d) | Employee benefit expense | 23057160000 | |
| (e) | Finance costs | 170640000 | |
| (f) | Depreciation, depletion and amortisation expense | 937840000 | |
| (f) | Other Expenses | ||
| 1 | Purchase of software licenses | 2297470000 | 2297470000 |
| 2 | Legal and professional fees | 603150000 | 603150000 |
| 3 | Travelling and conveyance | 563970000 | 563970000 |
| 4 | Miscellaneous expenses | 124710000 | 124710000 |
| 5 | Recruitment expenses | 73510000 | 73510000 |
| 6 | Advertisement, conference and sponsorship fees | 36990000 | 36990000 |
| 7 | Rent | 37930000 | 37930000 |
| 8 | Allowance for expected credit loss (net) | 24820000 | 24820000 |
| 9 | Training and seminars | 42750000 | 42750000 |
| 10 | Other Expenses | 357480000 | 357480000 |
| Total other expenses | 4162780000 | ||
| Total expenses | 28328420000 | ||
| 3 | Total profit before exceptional items and tax | 5554070000 | |
| 4 | Exceptional items | 0 | |
| 5 | Total profit before tax | 5554070000 | |
| 6 | Tax expense | ||
| 7 | Current tax | 1345940000 | |
| 8 | Deferred tax | -41230000 | |
| 9 | Total tax expenses | 1304710000 | |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | |
| 11 | Net Profit Loss for the period from continuing operations | 4249360000 | |
| 12 | Profit (loss) from discontinued operations before tax | 0 | |
| 13 | Tax expense of discontinued operations | 0 | |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | |
| 16 | Total profit (loss) for period | 4249360000 | |
| 17 | Other comprehensive income net of taxes | 233130000 | |
| 18 | Total Comprehensive Income for the period | 4482490000 | |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 4482490000 | ||
| Total profit or loss, attributable to non-controlling interests | 0 | ||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 4482490000 | ||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0 | ||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 782000000 | ||
| Face value of equity share capital | 5 | ||
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 27.43 | ||
| Diluted earnings (loss) per share from continuing operations | 27.21 | ||
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | ||
| Diluted earnings (loss) per share from discontinued operations | 0 | ||
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 27.43 | ||
| Diluted earnings (loss) per share from continuing and discontinued operations | 27.21 | ||
| 24 | Debt equity ratio | 0 | |
| 25 | Debt service coverage ratio | 0 | |
| 26 | Interest service coverage ratio | 0 | |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
Disclosure of notes on financial results |
|||
|---|---|---|---|
| Textual Information(1) | Due to character limitation in filling the notes in this tab, please refer to our submission under Ref. No. NSE & BSE / 2025-26 / 094 dated July 23, 2025, which covers the financial results under Regulation 33 of the SEBI (LODR) Regulations, 2015 including notes thereto. | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Apr-2025 | ||||||
| Date of end of reporting period | 30-Jun-2025 | ||||||
| Whether accounts are audited or unaudited | Audited | ||||||
| Nature of report standalone or consolidated | Consolidated | ||||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 11301440000 | 11301440000 | ||||
| 2 | Healthcare & Life Sciences | 8426900000 | 8426900000 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 13607530000 | 13607530000 | ||||
| Total Segment Revenue | 33335870000 | ||||||
| Less: Inter segment revenue | 0 | 0 | |||||
| Revenue from operations | 33335870000 | ||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 3885200000 | 3885200000 | ||||
| 2 | Healthcare & Life Sciences | 3041490000 | 3041490000 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 4900370000 | 4900370000 | ||||
| Total Profit before tax | 11827060000 | ||||||
| i. Finance cost | 170640000 | 170640000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 7195590000 | 7195590000 | |||||
| Profit before tax | 4460830000 | ||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 8427080000 | 8427080000 | ||||
| 2 | Healthcare & Life Sciences | 7556810000 | 7556810000 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 13036760000 | 13036760000 | ||||
| Total Segment Asset | 29020650000 | 29020650000 | |||||
| Un-allocable Assets | 65166840000 | 65166840000 | |||||
| Net Segment Asset | 94187490000 | 94187490000 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 0 | 0 | ||||
| 2 | Healthcare & Life Sciences | 0 | 0 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 0 | 0 | ||||
| Total Segment Liabilities | 0 | 0 | |||||
| Un-allocable Liabilities | 0 | 0 | |||||
| Net Segment Liabilities | 0 | 0 | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Audited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of the defined benefit liabilities / asset | 34720000 | 34720000 |
| Total Amount of items that will not be reclassified to profit and loss | 34720000 | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 8740000 | |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Effective portion of cash flow hedge (net of tax) | 163840000 | 163840000 |
| 2 | Exchange differences in translating the financial statements of foreign operations | 84540000 | 84540000 |
| Total Amount of items that will be reclassified to profit and loss | 248380000 | ||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 41230000 | |
| 5 | Total Other comprehensive income | 233130000 | |